相似文献
1
An innovative approach to screening and chemoprophylaxis among contacts of leprosy patients in low endemic settings: experiences from Cambodia.
PLoS Negl Trop Dis. 2019 Mar 28;13(3):e0007039. doi: 10.1371/journal.pntd.0007039. eCollection 2019 Mar.
2
3
Leprosy elimination campaigns.
Wkly Epidemiol Rec. 2000 Nov 10;75(45):361-6.
4
Leprosy elimination--how far?
Lepr Rev. 2004 Mar;75(1):101-2.
5
Retrospective active case finding in Cambodia: An innovative approach to leprosy control in a low-endemic country.
Acta Trop. 2018 Apr;180:26-32. doi: 10.1016/j.actatropica.2017.12.031. Epub 2017 Dec 28.
6
Leprosy New Case Detection Trends and the Future Effect of Preventive Interventions in Pará State, Brazil: A Modelling Study.
PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004507. doi: 10.1371/journal.pntd.0004507. eCollection 2016 Mar.
7
Features of leprosy transmission in pocket villages at low endemic situation in China.
Indian J Lepr. 2010 Apr-Jun;82(2):73-8.
8
Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy Post-Exposure Prophylaxis program in Cambodia.
Acta Trop. 2021 Dec;224:106138. doi: 10.1016/j.actatropica.2021.106138. Epub 2021 Sep 22.
9
Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Clin Dermatol. 2015 Jan-Feb;33(1):19-25. doi: 10.1016/j.clindermatol.2014.07.009.
10
Leprosy control activities integration into the general health system, in the endemic area of South Gujarat region.
Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):611-3. doi: 10.4103/0378-6323.57728.
引用本文的文献
1
Acceptability and feasibility of chemoprophylaxis with single-dose rifampicin in four leprosy-endemic districts in Benin.
PLoS Negl Trop Dis. 2025 Apr 28;19(4):e0013057. doi: 10.1371/journal.pntd.0013057. eCollection 2025 Apr.
2
A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for Leprosy.
Trop Med Infect Dis. 2025 Mar 21;10(4):84. doi: 10.3390/tropicalmed10040084.
3
Temporal trends and spatial analysis of leprosy surveillance indicators in the municipalities of the state of Mato Grosso, 2008-2022.
Rev Soc Bras Med Trop. 2024 Oct 28;57:e004192024. doi: 10.1590/0037-8682-0145-2024. eCollection 2024.
4
Community-Based Intervention for Active Detection and Provision of Single-Dose Rifampicin Post-Exposure Prophylaxis to Household Contacts of Leprosy in Bolivia.
Trop Med Infect Dis. 2024 May 1;9(5):101. doi: 10.3390/tropicalmed9050101.
5
The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.
Lepr Rev. 2018;89(2):102-116. doi: 10.47276/lr.89.2.102.
6
Implementation approaches for leprosy prevention with single-dose rifampicin: A support tool for decision making.
PLoS Negl Trop Dis. 2022 Oct 17;16(10):e0010792. doi: 10.1371/journal.pntd.0010792. eCollection 2022 Oct.
7
High yield of retrospective active case finding for leprosy in Comoros.
PLoS Negl Trop Dis. 2022 Mar 3;16(3):e0010158. doi: 10.1371/journal.pntd.0010158. eCollection 2022 Mar.
8
PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique and Tanzania.
BMJ Open. 2021 Aug 26;11(8):e046125. doi: 10.1136/bmjopen-2020-046125.
9
A comprehensive research agenda for zero leprosy.
Infect Dis Poverty. 2020 Nov 12;9(1):156. doi: 10.1186/s40249-020-00774-4.
10
The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Res Rep Trop Med. 2020 Oct 15;11:97-117. doi: 10.2147/RRTM.S190300. eCollection 2020.
本文引用的文献
1
The Leprosy Post-Exposure Prophylaxis (LPEP) programme: update and interim analysis.
Lepr Rev. 2018;89(2):102-116. doi: 10.47276/lr.89.2.102.
2
Retrospective active case finding in Cambodia: An innovative approach to leprosy control in a low-endemic country.
Acta Trop. 2018 Apr;180:26-32. doi: 10.1016/j.actatropica.2017.12.031. Epub 2017 Dec 28.
3
Multidrug therapy for leprosy: a game changer on the path to elimination.
Lancet Infect Dis. 2017 Sep;17(9):e293-e297. doi: 10.1016/S1473-3099(17)30418-8. Epub 2017 Jul 7.
4
"I Wasted 3 Years, Thinking It's Not a Problem": Patient and Health System Delays in Diagnosis of Leprosy in India: A Mixed-Methods Study.
PLoS Negl Trop Dis. 2017 Jan 12;11(1):e0005192. doi: 10.1371/journal.pntd.0005192. eCollection 2017 Jan.
5
Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
BMJ Open. 2016 Nov 17;6(11):e013633. doi: 10.1136/bmjopen-2016-013633.
6
Update on the epidemiology, diagnosis, and treatment of leprosy.
Med Mal Infect. 2015 Sep;45(9):383-93. doi: 10.1016/j.medmal.2015.09.002. Epub 2015 Oct 1.
7
The missing millions: a threat to the elimination of leprosy.
PLoS Negl Trop Dis. 2015 Apr 23;9(4):e0003658. doi: 10.1371/journal.pntd.0003658. eCollection 2015 Apr.
8
Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Clin Dermatol. 2015 Jan-Feb;33(1):19-25. doi: 10.1016/j.clindermatol.2014.07.009.
9
Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.
BMJ. 2008 Apr 5;336(7647):761-4. doi: 10.1136/bmj.39500.885752.BE. Epub 2008 Mar 10.
10
Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy.
J Infect Dis. 2006 Feb 1;193(3):346-53. doi: 10.1086/499278. Epub 2005 Dec 28.
Zotero 插件